De novo ERBB2 amplification causing intrinsic resistance to erlotinib in EGFR-L858R mutated TKI-naïve lung adenocarcinoma.

Lung Cancer 2017 12 24;114:108-110. Epub 2017 Aug 24.

Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.08.018DOI Listing
December 2017
6 Reads

Publication Analysis

Top Keywords

intrinsic resistance
4
causing intrinsic
4
mutated tki-naïve
4
resistance erlotinib
4
erlotinib egfr-l858r
4
egfr-l858r mutated
4
tki-naïve lung
4
lung adenocarcinoma
4
novo erbb2
4
amplification causing
4
erbb2 amplification
4
lung
1
tki-naïve
1
adenocarcinoma
1
erlotinib
1
causing
1
amplification
1
intrinsic
1
resistance
1
egfr-l858r
1

Similar Publications